HP

HealthInvest Partners Portfolio holdings

AUM $234M
1-Year Return 10.88%
This Quarter Return
+18.09%
1 Year Return
+10.88%
3 Year Return
–
5 Year Return
–
10 Year Return
–
AUM
$151M
AUM Growth
–
Cap. Flow
+$151M
Cap. Flow %
100%
Top 10 Hldgs %
64.81%
Holding
17
New
17
Increased
–
Reduced
–
Closed
–

Top Buys

1
SUPN icon
Supernus Pharmaceuticals
SUPN
+$11.7M
2
CHRS icon
Coherus Oncology, Inc. Common Stock
CHRS
+$10.4M
3
VTRS icon
Viatris
VTRS
+$9.84M
4
CI icon
Cigna
CI
+$9.78M
5
COLL icon
Collegium Pharmaceutical
COLL
+$9.61M

Top Sells

No sells this quarter

Sector Composition

1 Healthcare 100%
Name Market Value Portfolio Weight Shares or Principal Shares
Change % 		Capital Flow
SUPN icon
1
Supernus Pharmaceuticals
SUPN
$2.47B
$11.7M 7.75%
+465,000
New +$11.7M
CHRS icon
2
Coherus Oncology, Inc. Common Stock
CHRS
$158M
$10.4M 6.91%
+600,000
New +$10.4M
VTRS icon
3
Viatris
VTRS
$11.1B
$9.84M 6.52%
+525,000
New +$9.84M
CI icon
4
Cigna
CI
$78.5B
$9.78M 6.48%
+47,000
New +$9.78M
COLL icon
5
Collegium Pharmaceutical
COLL
$1.12B
$9.61M 6.37%
+480,000
New +$9.61M
IRWD icon
6
Ironwood Pharmaceuticals
IRWD
$211M
$9.51M 6.3%
+835,000
New +$9.51M
UHS icon
7
Universal Health Services
UHS
$11.9B
$9.35M 6.19%
+68,000
New +$9.35M
ABBV icon
8
AbbVie
ABBV
$382B
$9.32M 6.17%
+87,000
New +$9.32M
MCK icon
9
McKesson
MCK
$86.3B
$9.22M 6.1%
+53,000
New +$9.22M
COR icon
10
Cencora
COR
$56.2B
$9.09M 6.02%
+93,000
New +$9.09M
BMY icon
11
Bristol-Myers Squibb
BMY
$94.3B
$9.06M 6%
+146,000
New +$9.06M
CAH icon
12
Cardinal Health
CAH
$35.4B
$9.05M 5.99%
+169,000
New +$9.05M
TEVA icon
13
Teva Pharmaceuticals
TEVA
$21.4B
$8.83M 5.85%
+915,000
New +$8.83M
ARAY icon
14
Accuray
ARAY
$181M
$6.88M 4.56%
+1,650,000
New +$6.88M
ATRS
15
DELISTED
Antares Pharma, Inc.
ATRS
$6.86M 4.55%
+1,720,000
New +$6.86M
BDSI
16
DELISTED
BioDelivery Sciences International, Inc.
BDSI
$6.62M 4.38%
+1,575,000
New +$6.62M
CPRX icon
17
Catalyst Pharmaceutical
CPRX
$2.46B
$5.85M 3.87%
+1,750,000
New +$5.85M